NCT00072670 2014-04-08
A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Completed
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Massachusetts General Hospital